Brought to you by 
Grail and Cirina merge
14 Sep 2020
Executive Summary
Molecular diagnostics firms Grail Inc. and Cirina Ltd. agreed to combine in a deal that gives two-year-old Grail greater product potential and access to the noninvasive molecular diagnostics market in Asia. Financial details were not disclosed.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com